VisEn plans to use the funds for working capital and to expand its commercialization efforts worldwide. The company specializes in fluorescence-based agents and systems designed for noninvasive in vivo imaging for research and medicine.
VisEn secures financing, October 26, 2007
VisEn brings molecular imaging probe to market, June 7, 2007
VisEn, Merck to develop molecular imaging agents, March 6, 2007
VisEn, Olympus expand distribution relationship, December 11, 2006
Olympus, VisEn ink Japanese deal, December 11, 2006
Copyright © 2008 AuntMinnie.com